CANNABIDIOL

CANNABIDIOL was reported 24103 times

CANNABIDIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 18 0.6923
1 RETRO-ORBITAL NEOPLASM 18 0.3396
2 CORPUS CALLOSOTOMY 8 0.2500
3 GELASTIC SEIZURE 7 0.2414
4 SEIZURE CLUSTER 177 0.2135
5 ELECTROENCEPHALOGRAM 11 0.1964
6 ATONIC SEIZURES 153 0.1781
7 VAGAL NERVE STIMULATOR IMPLANTATION 54 0.1765
8 CHANGE IN SEIZURE PRESENTATION 95 0.1468
9 LENNOX-GASTAUT SYNDROME 27 0.1189
10 RETT SYNDROME 7 0.1094
11 EMERGENCY CARE 309 0.1018
12 MEDICAL DEVICE BATTERY REPLACEMENT 13 0.0963
13 CARDIAC STEATOSIS 7 0.0946
14 AORTIC VALVE THICKENING 14 0.0870
15 NEUROBLASTOMA RECURRENT 17 0.0837
16 PRODUCT ADMINISTRATION INTERRUPTED 615 0.0783
17 EPILEPTIC ENCEPHALOPATHY 17 0.0762
18 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 40 0.0746
19 MITRAL VALVE THICKENING 19 0.0638
20 GREATER TROCHANTERIC PAIN SYNDROME 13 0.0634
21 TONIC CONVULSION 85 0.0599
22 WEIGHT ABNORMAL 130 0.0541
23 SEIZURE 6169 0.0534
24 NEUROPROSTHESIS IMPLANTATION 7 0.0504
25 POST VIRAL FATIGUE SYNDROME 12 0.0496
26 MYOCLONIC EPILEPSY 75 0.0494
27 ANTICONVULSANT DRUG LEVEL INCREASED 79 0.0489
28 MULTIPLE-DRUG RESISTANCE 142 0.0457
29 GASTROSTOMY TUBE SITE COMPLICATION 9 0.0450
30 PRODUCT SUPPLY ISSUE 304 0.0425
31 ANTICONVULSANT DRUG LEVEL ABNORMAL 7 0.0398
32 PYELONEPHRITIS CHRONIC 7 0.0372
33 COMPLEMENT FACTOR C4 DECREASED 7 0.0365
34 FEEDING INTOLERANCE 15 0.0333
35 DEVICE RELATED THROMBOSIS 30 0.0304
36 INCREASED NEED FOR SLEEP 7 0.0300
37 DEFIANT BEHAVIOUR 9 0.0292
38 BEHAVIOUR DISORDER 157 0.0290
39 COMPLEMENT FACTOR C3 DECREASED 7 0.0287
40 PETIT MAL EPILEPSY 141 0.0276
41 BRAIN OPERATION 62 0.0271
42 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0270
43 THERAPY RESPONDER 13 0.0265
44 METAL POISONING 15 0.0259
45 MICROSPORIDIA INFECTION 9 0.0256
46 POVERTY OF SPEECH 10 0.0255
47 INFANTILE SPASMS 18 0.0249
48 AMMONIA ABNORMAL 10 0.0248
49 INTELLECTUAL DISABILITY 37 0.0244
50 GENERALISED TONIC-CLONIC SEIZURE 397 0.0240
51 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 11 0.0235
52 DRUG WITHDRAWAL CONVULSIONS 39 0.0219
53 HEAD BANGING 12 0.0211
54 ADENOIDECTOMY 8 0.0206
55 WOUND ABSCESS 7 0.0201
56 GASTROSTOMY 31 0.0200
57 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0199
58 CHRONIC RESPIRATORY DISEASE 7 0.0198
59 GRANULOCYTE COUNT INCREASED 8 0.0198
60 SELF-DESTRUCTIVE BEHAVIOUR 17 0.0195
61 FEEDING TUBE USER 7 0.0191
62 MEDICAL DEVICE CHANGE 10 0.0188
63 MUSCLE MASS 8 0.0177
64 STATUS EPILEPTICUS 200 0.0177
65 FOCAL DYSCOGNITIVE SEIZURES 20 0.0176
66 HOSPITALISATION 2670 0.0174
67 DACTYLITIS 17 0.0173
68 BLOOD PRESSURE DIASTOLIC ABNORMAL 44 0.0173
69 RHINOVIRUS INFECTION 67 0.0172
70 TRACHEITIS 13 0.0171
71 DROOLING 117 0.0169
72 PULMONARY VALVE INCOMPETENCE 24 0.0164
73 INAPPROPRIATE AFFECT 26 0.0164
74 TENOSYNOVITIS STENOSANS 9 0.0162
75 FOOD REFUSAL 14 0.0160
76 TOXIC SHOCK SYNDROME 10 0.0159
77 PARTIAL SEIZURES 77 0.0147
78 AORTIC DILATATION 16 0.0144
79 FOETAL EXPOSURE TIMING UNSPECIFIED 10 0.0139
80 POSTICTAL STATE 14 0.0135
81 HAND DERMATITIS 9 0.0130
82 ENTHESOPATHY 20 0.0128
83 METAPNEUMOVIRUS INFECTION 10 0.0128
84 ENTEROVIRUS INFECTION 11 0.0127
85 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 76 0.0125
86 BLOOD PRESSURE DIASTOLIC DECREASED 92 0.0125
87 HYPERVIGILANCE 12 0.0124
88 BLINDNESS CORTICAL 6 0.0122
89 PRODUCT PREPARATION ISSUE 79 0.0120
90 TRICUSPID VALVE INCOMPETENCE 94 0.0118
91 BLOOD PRESSURE SYSTOLIC ABNORMAL 29 0.0117
92 PRESCRIBED OVERDOSE 227 0.0117
93 STARING 28 0.0116
94 ECHOCARDIOGRAM ABNORMAL 16 0.0114
95 MEDICAL DEVICE SITE INFECTION 7 0.0113
96 HEAD TITUBATION 15 0.0109
97 ENDOCRINE OPHTHALMOPATHY 9 0.0104
98 PRODUCT DISTRIBUTION ISSUE 93 0.0100
99 AMMONIA INCREASED 51 0.0100
100 DERMATITIS DIAPER 7 0.0099
101 ALCOHOL INTOLERANCE 7 0.0099
102 INTENSIVE CARE 14 0.0098
103 CLONIC CONVULSION 7 0.0096
104 REACTION TO EXCIPIENT 22 0.0095
105 TESTICULAR ATROPHY 8 0.0092
106 ARTHRODESIS 9 0.0088
107 MOANING 10 0.0088
108 AORTIC VALVE INCOMPETENCE 37 0.0087
109 SIMPLE PARTIAL SEIZURES 7 0.0087
110 PRODUCT CONTAINER SEAL ISSUE 15 0.0086
111 SCREAMING 54 0.0085
112 SEDATION 221 0.0084
113 CEREBRAL PALSY 8 0.0084
114 MYOCARDIAL FIBROSIS 7 0.0083
115 AGGRESSION 411 0.0082
116 AURA 15 0.0080
117 PSYCHOMOTOR HYPERACTIVITY 132 0.0079
118 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 133 0.0078
119 STEREOTYPY 7 0.0074
120 RESPIRATORY TRACT INFECTION VIRAL 17 0.0073
121 PRODUCT USE IN UNAPPROVED INDICATION 1809 0.0073
122 PARAINFLUENZAE VIRUS INFECTION 11 0.0072
123 ASPIRATION 77 0.0070
124 EPILEPSY 209 0.0068
125 SOMNOLENCE 1340 0.0066
126 PRODUCT CONTAINER ISSUE 57 0.0066
127 MEAN CELL HAEMOGLOBIN INCREASED 11 0.0066
128 CARDIAC DEATH 8 0.0066
129 CHRONIC RESPIRATORY FAILURE 8 0.0066
130 GINGIVAL HYPERTROPHY 10 0.0066
131 FEBRILE CONVULSION 8 0.0066
132 HYPERSOMNIA 188 0.0066
133 JOINT CONTRACTURE 7 0.0065
134 ANTICONVULSANT DRUG LEVEL DECREASED 9 0.0064
135 TRACHEOSTOMY 9 0.0063
136 NONINFECTIVE GINGIVITIS 9 0.0062
137 OBSTRUCTIVE SLEEP APNOEA SYNDROME 9 0.0062
138 DRUG LEVEL INCREASED 98 0.0059
139 RESPIRATORY SYNCYTIAL VIRUS INFECTION 51 0.0059
140 MITRAL VALVE INCOMPETENCE 66 0.0058
141 FINGER DEFORMITY 28 0.0058
142 SUBSTANCE USE 9 0.0058
143 LETHARGY 330 0.0057
144 THERAPEUTIC PROCEDURE 8 0.0057
145 METASTASES TO SPINE 19 0.0056
146 NASAL ULCER 9 0.0056
147 GASTROINTESTINAL TUBE INSERTION 14 0.0056
148 PNEUMONIA ASPIRATION 140 0.0056
149 PRODUCT MONITORING ERROR 8 0.0055
150 LARGE INTESTINE POLYP 38 0.0055
151 WEIGHT FLUCTUATION 57 0.0054
152 ABNORMAL BEHAVIOUR 213 0.0054
153 RADICULOPATHY 14 0.0053
154 AUTISM SPECTRUM DISORDER 29 0.0053
155 PRODUCT COLOUR ISSUE 27 0.0053
156 ATAXIA 61 0.0051
157 SEDATION COMPLICATION 13 0.0051
158 BLOOD PRESSURE DIASTOLIC INCREASED 23 0.0050
159 BODY TEMPERATURE DECREASED 49 0.0050
160 SLOW SPEECH 12 0.0049
161 DYSCHEZIA 15 0.0049
162 INSURANCE ISSUE 75 0.0049
163 SKIN LACERATION 53 0.0049
164 PRODUCT DOSE OMISSION 318 0.0049
165 HYPERAMMONAEMIA 24 0.0048
166 EYELID DISORDER 11 0.0048
167 SEIZURE LIKE PHENOMENA 8 0.0047
168 HYPOTONIA 47 0.0047
169 IRRITABILITY 282 0.0047
170 MOOD ALTERED 126 0.0046
171 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 7 0.0046
172 SINUS HEADACHE 27 0.0045
173 DAYDREAMING 7 0.0045
174 LIQUID PRODUCT PHYSICAL ISSUE 33 0.0045
175 BLOOD PRESSURE SYSTOLIC INCREASED 86 0.0044
176 APHTHOUS ULCER 34 0.0044
177 TONGUE BITING 9 0.0044
178 DISINHIBITION 7 0.0043
179 AGITATION 313 0.0043
180 FOETAL DEATH 22 0.0042
181 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 14 0.0042
182 FACE INJURY 16 0.0042
183 PRODUCT CONTAMINATION 15 0.0042
184 MITRAL VALVE PROLAPSE 7 0.0042
185 ANGER 142 0.0042
186 TONSILLECTOMY 7 0.0042
187 GAZE PALSY 7 0.0041
188 LIMB MASS 9 0.0041
189 PRODUCT DOSE OMISSION ISSUE 1191 0.0040
190 SUSPECTED COVID-19 13 0.0039
191 ENDOTRACHEAL INTUBATION 11 0.0039
192 INCREASED BRONCHIAL SECRETION 10 0.0039
193 MEAN CELL HAEMOGLOBIN DECREASED 7 0.0038
194 VITAMIN B12 DECREASED 11 0.0038
195 WEIGHT INCREASED 845 0.0038
196 LUMBAR SPINAL STENOSIS 11 0.0038
197 THERAPY CHANGE 37 0.0038
198 SALIVARY HYPERSECRETION 37 0.0037
199 CYSTIC FIBROSIS 20 0.0036
200 FAECES SOFT 26 0.0036
201 SLEEP TERROR 15 0.0036
202 NAIL DISORDER 31 0.0035
203 DRUG RESISTANCE 91 0.0035
204 HEPATIC PAIN 15 0.0035
205 INCREASED APPETITE 67 0.0035
206 DRUG INTERACTION 554 0.0035
207 DRUG TITRATION ERROR 9 0.0035
208 ELECTROENCEPHALOGRAM ABNORMAL 11 0.0035
209 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
210 LOGORRHOEA 12 0.0034
211 GASTROENTERITIS VIRAL 61 0.0034
212 EYE CONTUSION 7 0.0033
213 SLEEP DEFICIT 7 0.0033
214 WRONG DOSE 8 0.0033
215 PRODUCT TEMPERATURE EXCURSION ISSUE 17 0.0033
216 AFFECTIVE DISORDER 26 0.0033
217 CRANIOCEREBRAL INJURY 10 0.0033
218 HYPERPHAGIA 13 0.0033
219 JAW FRACTURE 7 0.0032
220 FEELING DRUNK 24 0.0032
221 DYSPHEMIA 14 0.0032
222 WEIGHT DECREASED 890 0.0032
223 DECREASED APPETITE 735 0.0032
224 HIP SURGERY 17 0.0031
225 GASTROINTESTINAL HYPOMOTILITY 7 0.0031
226 THERAPEUTIC REACTION TIME DECREASED 9 0.0031
227 RESPIRATORY DISORDER 92 0.0031
228 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
229 PRODUCT TASTE ABNORMAL 41 0.0030
230 APPETITE DISORDER 20 0.0030
231 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
232 HEAD INJURY 94 0.0030
233 PHARYNGITIS STREPTOCOCCAL 32 0.0030
234 VARICELLA 7 0.0029
235 TENOSYNOVITIS 8 0.0029
236 CRYING 105 0.0029
237 OFF LABEL USE 2520 0.0029
238 ATTENTION DEFICIT HYPERACTIVITY DISORDER 12 0.0028
239 METASTASES TO LIVER 50 0.0028
240 FAECAL CALPROTECTIN INCREASED 9 0.0028
241 VIRAL INFECTION 94 0.0028
242 PHARYNGITIS 35 0.0028
243 SURGERY 165 0.0028
244 PRODUCT USE COMPLAINT 44 0.0028
245 GAIT INABILITY 93 0.0028
246 FACIAL BONES FRACTURE 10 0.0028
247 SOCIAL AVOIDANT BEHAVIOUR 16 0.0028
248 TOOTH INJURY 12 0.0028
249 FEEDING DISORDER 56 0.0028
250 ADENOVIRUS INFECTION 8 0.0028
251 DIARRHOEA 1776 0.0027
252 OBSESSIVE-COMPULSIVE DISORDER 22 0.0027
253 NECK INJURY 8 0.0027
254 ENURESIS 11 0.0027
255 AORTIC ARTERIOSCLEROSIS 7 0.0027
256 MYOCLONUS 32 0.0027
257 IMPULSIVE BEHAVIOUR 10 0.0027
258 LIVER FUNCTION TEST INCREASED 56 0.0026
259 ACUTE RESPIRATORY FAILURE 50 0.0026
260 GINGIVITIS 14 0.0026
261 BLOOD SODIUM INCREASED 7 0.0026
262 SLEEP DISORDER 182 0.0026
263 DRUG EFFECT LESS THAN EXPECTED 38 0.0026
264 THERAPEUTIC RESPONSE UNEXPECTED 115 0.0026
265 PRE-EXISTING CONDITION IMPROVED 16 0.0026
266 DYSLIPIDAEMIA 13 0.0026
267 HEPATIC ENZYME INCREASED 174 0.0025
268 INFUSION SITE PRURITUS 8 0.0025
269 INITIAL INSOMNIA 26 0.0025
270 VITREOUS HAEMORRHAGE 7 0.0025
271 RETCHING 54 0.0025
272 SUBSTANCE USE DISORDER 8 0.0025
273 FAILURE TO THRIVE 13 0.0025
274 EYE MOVEMENT DISORDER 17 0.0025
275 POOR QUALITY PRODUCT ADMINISTERED 26 0.0025
276 INTENTIONAL PRODUCT USE ISSUE 216 0.0025
277 SPINAL FUSION SURGERY 10 0.0025
278 EAR INFECTION 65 0.0024
279 HYPERAESTHESIA 20 0.0024
280 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
281 HYPERACUSIS 9 0.0024
282 RALES 14 0.0024
283 URINARY RETENTION 80 0.0024
284 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 131 0.0024
285 NERVE COMPRESSION 22 0.0024
286 STRABISMUS 7 0.0024
287 URINE ODOUR ABNORMAL 14 0.0024
288 ILLNESS 245 0.0024
289 EATING DISORDER 50 0.0023
290 BREAST CANCER METASTATIC 25 0.0023
291 VIRAL UPPER RESPIRATORY TRACT INFECTION 11 0.0023
292 ENCEPHALITIS 16 0.0023
293 PRODUCT PRESCRIBING ISSUE 50 0.0023
294 MASTICATION DISORDER 7 0.0023
295 CATATONIA 12 0.0023
296 SCOLIOSIS 14 0.0023
297 GASTROINTESTINAL SOUNDS ABNORMAL 11 0.0022
298 MUSCLE TWITCHING 51 0.0022
299 RESPIRATORY DISTRESS 61 0.0022
300 ASPHYXIA 18 0.0022
301 URINE ABNORMALITY 10 0.0022
302 ABNORMAL FAECES 18 0.0022
303 PNEUMONIA VIRAL 7 0.0022
304 POOR QUALITY SLEEP 47 0.0022
305 MYDRIASIS 28 0.0022
306 PNEUMONIA BACTERIAL 20 0.0022
307 HEART RATE DECREASED 76 0.0022
308 HYPERTRANSAMINASAEMIA 15 0.0022
309 OXYGEN SATURATION DECREASED 120 0.0021
310 DEVELOPMENTAL DELAY 19 0.0021
311 FEELING JITTERY 40 0.0021
312 MENINGITIS 14 0.0021
313 COMMUNICATION DISORDER 8 0.0021
314 INFUSION SITE EXTRAVASATION 13 0.0021
315 POLYARTHRITIS 11 0.0021
316 POTENTIATING DRUG INTERACTION 7 0.0021
317 BLOOD PRESSURE FLUCTUATION 50 0.0021
318 INTENTIONAL SELF-INJURY 42 0.0021
319 BRONCHIECTASIS 14 0.0021
320 HORMONE LEVEL ABNORMAL 10 0.0020
321 RESTLESSNESS 75 0.0020
322 SEASONAL ALLERGY 29 0.0020
323 PERSONALITY CHANGE 19 0.0020
324 BRUXISM 11 0.0020
325 CONDITION AGGRAVATED 616 0.0020
326 HOSPICE CARE 20 0.0020
327 DRUG SCREEN POSITIVE 16 0.0020
328 PNEUMONIA 652 0.0020
329 DYSTONIA 39 0.0020
330 HEPATIC ENZYME ABNORMAL 10 0.0020
331 ANAL INCONTINENCE 18 0.0020
332 FLUID INTAKE REDUCED 10 0.0020
333 BALANCE DISORDER 172 0.0020
334 HYPOTHERMIA 20 0.0020
335 SLUGGISHNESS 20 0.0020
336 SYNOVIAL CYST 9 0.0019
337 INSOMNIA 517 0.0019
338 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
339 HEPATIC STEATOSIS 36 0.0019
340 HYPOPHAGIA 49 0.0019
341 INTENTIONAL UNDERDOSE 14 0.0019
342 CEREBRAL DISORDER 14 0.0019
343 COVID-19 331 0.0019
344 RESPIRATION ABNORMAL 13 0.0019
345 AFFECT LABILITY 18 0.0019
346 DECREASED INTEREST 11 0.0019
347 DYSARTHRIA 70 0.0019
348 STRESS FRACTURE 10 0.0019
349 SNORING 7 0.0018
350 APATHY 27 0.0018
351 URINARY TRACT INFECTION 314 0.0018
352 INCORRECT DOSAGE ADMINISTERED 9 0.0018
353 BOWEL MOVEMENT IRREGULARITY 14 0.0018
354 CLAVICLE FRACTURE 7 0.0018
355 FAECALOMA 10 0.0018
356 ONYCHOMYCOSIS 8 0.0018
357 GINGIVAL DISORDER 7 0.0018
358 CORONAVIRUS INFECTION 12 0.0018
359 HYPERNATRAEMIA 9 0.0018
360 PRODUCT AVAILABILITY ISSUE 41 0.0018
361 WHEELCHAIR USER 8 0.0018
362 INCONTINENCE 19 0.0018
363 COVID-19 PNEUMONIA 21 0.0018
364 MOTOR DYSFUNCTION 18 0.0018
365 MANIA 29 0.0018
366 IMPAIRED GASTRIC EMPTYING 24 0.0018
367 TRANSAMINASES INCREASED 39 0.0018
368 SWELLING OF EYELID 11 0.0018
369 ANKYLOSING SPONDYLITIS 23 0.0017
370 BRAIN NEOPLASM 16 0.0017
371 DECREASED IMMUNE RESPONSIVENESS 17 0.0017
372 UPPER RESPIRATORY TRACT INFECTION 80 0.0017
373 BONE LOSS 26 0.0017
374 HEART RATE IRREGULAR 39 0.0017
375 ROSACEA 8 0.0017
376 GASTROINTESTINAL DISORDER 152 0.0017
377 NYSTAGMUS 9 0.0017
378 BRADYPHRENIA 11 0.0017
379 EYE INFECTION 19 0.0017
380 FOOD POISONING 9 0.0017
381 NEPHROLITHIASIS 77 0.0017
382 SELF-INJURIOUS IDEATION 7 0.0017
383 HALLUCINATIONS, MIXED 7 0.0017
384 MOOD SWINGS 53 0.0017
385 EUPHORIC MOOD 17 0.0017
386 TIC 9 0.0016
387 METASTASES TO BONE 27 0.0016
388 BLOOD SODIUM DECREASED 31 0.0016
389 GASTROINTESTINAL PAIN 18 0.0016
390 INTENTIONAL DOSE OMISSION 46 0.0016
391 VOMITING 753 0.0016
392 PSORIATIC ARTHROPATHY 65 0.0016
393 SECRETION DISCHARGE 20 0.0016
394 MELANOCYTIC NAEVUS 7 0.0016
395 CONSTIPATION 348 0.0016
396 DEATH 1374 0.0016
397 POISONING 20 0.0016
398 HICCUPS 13 0.0016
399 DRUG TOLERANCE 8 0.0016
400 FATIGUE 1231 0.0016
401 RECALLED PRODUCT ADMINISTERED 15 0.0016
402 NEURALGIA 38 0.0016
403 FALL 517 0.0016
404 CONCUSSION 12 0.0015
405 COGNITIVE DISORDER 72 0.0015
406 THROAT IRRITATION 69 0.0015
407 CHOKING 30 0.0015
408 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
409 INFLUENZA 170 0.0015
410 VITAMIN D DECREASED 13 0.0015
411 URINARY INCONTINENCE 45 0.0015
412 IMMUNE SYSTEM DISORDER 20 0.0015
413 SKIN ULCER 39 0.0015
414 PRODUCTIVE COUGH 72 0.0015
415 DYSKINESIA 61 0.0015
416 BRAIN INJURY 15 0.0015
417 POST-TRAUMATIC STRESS DISORDER 10 0.0015
418 FRUSTRATION TOLERANCE DECREASED 12 0.0015
419 DECUBITUS ULCER 12 0.0015
420 GINGIVAL BLEEDING 20 0.0015
421 RESPIRATORY TRACT INFECTION 38 0.0015
422 CARDIOTOXICITY 13 0.0015
423 ARTHROPATHY 81 0.0015
424 DRUG DIVERSION 9 0.0015
425 APHASIA 44 0.0015
426 PSYCHOTIC DISORDER 43 0.0015
427 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
428 PRODUCT DOSE OMISSION IN ERROR 41 0.0014
429 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
430 FLATULENCE 82 0.0014
431 ORAL DISCOMFORT 20 0.0014
432 PALLOR 39 0.0014
433 PRODUCT ODOUR ABNORMAL 15 0.0014
434 HIP FRACTURE 46 0.0014
435 C-REACTIVE PROTEIN INCREASED 52 0.0014
436 FOOD ALLERGY 11 0.0014
437 MUSCULOSKELETAL DISORDER 27 0.0014
438 QUALITY OF LIFE DECREASED 19 0.0014
439 CARDIAC VALVE DISEASE 8 0.0014
440 PSEUDOMONAS INFECTION 12 0.0014
441 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
442 IMPAIRED QUALITY OF LIFE 20 0.0014
443 DECREASED ACTIVITY 15 0.0014
444 ENCEPHALOPATHY 34 0.0014
445 COMPLICATION ASSOCIATED WITH DEVICE 20 0.0014
446 DRUG LEVEL DECREASED 14 0.0014
447 OESOPHAGITIS 15 0.0014
448 BODY TEMPERATURE INCREASED 28 0.0014
449 ABDOMINAL DISCOMFORT 230 0.0014
450 GASTRIC ULCER 26 0.0014
451 INCREASED UPPER AIRWAY SECRETION 7 0.0014
452 TOOTH FRACTURE 15 0.0014
453 MUSCULOSKELETAL CHEST PAIN 21 0.0014
454 DENTAL CARIES 15 0.0014
455 SUICIDAL IDEATION 123 0.0013
456 ALANINE AMINOTRANSFERASE INCREASED 82 0.0013
457 CHROMATURIA 30 0.0013
458 INFLAMMATORY BOWEL DISEASE 13 0.0013
459 LEUKOCYTOSIS 24 0.0013
460 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 94 0.0013
461 RESPIRATORY FAILURE 96 0.0013
462 HYPOXIA 46 0.0013
463 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
464 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8 0.0013
465 HYDROCEPHALUS 7 0.0013
466 APNOEA 10 0.0013
467 JAW DISORDER 7 0.0013
468 OSTEOARTHRITIS 54 0.0013
469 BLEPHAROSPASM 8 0.0013
470 GASTROOESOPHAGEAL REFLUX DISEASE 102 0.0013
471 SPINAL DISORDER 12 0.0013
472 PNEUMOTHORAX 20 0.0013
473 RENAL CYST 10 0.0013
474 FREQUENT BOWEL MOVEMENTS 34 0.0013
475 URINE OUTPUT DECREASED 11 0.0013
476 STREPTOCOCCAL INFECTION 7 0.0013
477 FEELING COLD 35 0.0013
478 HEPATIC CYTOLYSIS 16 0.0013
479 PRODUCT LEAKAGE 7 0.0012
480 MENTAL DISORDER 54 0.0012
481 RESPIRATORY RATE INCREASED 11 0.0012
482 INCOHERENT 8 0.0012
483 DELUSION 19 0.0012
484 COORDINATION ABNORMAL 17 0.0012
485 LIGAMENT SPRAIN 12 0.0012
486 NASAL CONGESTION 71 0.0012
487 MENSTRUAL DISORDER 10 0.0012
488 SKIN REACTION 17 0.0012
489 ELECTROLYTE IMBALANCE 14 0.0012
490 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
491 SPEECH DISORDER 63 0.0012
492 SYRINGE ISSUE 21 0.0012
493 LIMB DISCOMFORT 37 0.0012
494 BREAST MASS 8 0.0012
495 MENTAL STATUS CHANGES 33 0.0012
496 ENERGY INCREASED 7 0.0012
497 BRADYKINESIA 7 0.0012
498 PRODUCT COMPLAINT 30 0.0012
499 GAIT DISTURBANCE 226 0.0012
500 HAEMORRHOIDS 23 0.0012
501 WRIST FRACTURE 14 0.0012
502 DRUG ABUSE 97 0.0012
503 PERIPHERAL COLDNESS 16 0.0012
504 DYSSTASIA 34 0.0012
505 MALNUTRITION 13 0.0012
506 FOOT FRACTURE 22 0.0012
507 HYSTERECTOMY 10 0.0012
508 FIBROMYALGIA 28 0.0012
509 DYSPHAGIA 109 0.0011
510 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
511 CYANOSIS 18 0.0011
512 HAEMATOCHEZIA 63 0.0011
513 GASTRITIS 30 0.0011
514 SKIN DISORDER 38 0.0011
515 AMNESIA 74 0.0011
516 LARYNGEAL OEDEMA 7 0.0011
517 EMOTIONAL DISORDER 35 0.0011
518 FULL BLOOD COUNT ABNORMAL 12 0.0011
519 PYREXIA 390 0.0011
520 TREMOR 187 0.0011
521 ILEUS 14 0.0011
522 MIDDLE INSOMNIA 21 0.0011
523 BLOOD DISORDER 9 0.0011
524 THIRST 20 0.0011
525 ORAL PAIN 25 0.0011
526 GASTROINTESTINAL INFECTION 10 0.0011
527 DISTURBANCE IN ATTENTION 60 0.0011
528 INFUSION SITE SWELLING 7 0.0011
529 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 53 0.0011
530 PARANOIA 19 0.0011
531 INFUSION RELATED REACTION 73 0.0011
532 SLEEP APNOEA SYNDROME 21 0.0011
533 CYSTITIS 35 0.0011
534 DEPRESSED MOOD 58 0.0011
535 DRUG INEFFECTIVE 1445 0.0011
536 PRODUCT USE ISSUE 206 0.0011
537 UNRESPONSIVE TO STIMULI 28 0.0011
538 BRAIN FOG 17 0.0011
539 IRON DEFICIENCY ANAEMIA 10 0.0011
540 TOOTH ABSCESS 11 0.0011
541 DIPLOPIA 28 0.0011
542 HALLUCINATION 81 0.0011
543 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
544 TREATMENT FAILURE 89 0.0011
545 TENDON DISORDER 7 0.0011
546 ECZEMA 56 0.0011
547 HAEMATEMESIS 27 0.0011
548 PRODUCT FORMULATION ISSUE 7 0.0011
549 ILL-DEFINED DISORDER 64 0.0011
550 MICTURITION URGENCY 12 0.0010
551 DEHYDRATION 140 0.0010
552 DRY MOUTH 85 0.0010
553 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
554 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
555 TREATMENT NONCOMPLIANCE 57 0.0010
556 LOWER LIMB FRACTURE 20 0.0010
557 JOINT DISLOCATION 11 0.0010
558 THYROID DISORDER 16 0.0010
559 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35 0.0010
560 UVEITIS 14 0.0010
561 PELVIC FRACTURE 8 0.0010
562 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
563 RASH PAPULAR 23 0.0010
564 GRIP STRENGTH DECREASED 9 0.0010
565 RHINORRHOEA 66 0.0010
566 COUGH 285 0.0010
567 MUSCULOSKELETAL STIFFNESS 89 0.0010
568 NASOPHARYNGITIS 187 0.0010
569 BLOOD IRON DECREASED 12 0.0010
570 BLOOD ALBUMIN DECREASED 8 0.0010
571 HALLUCINATION, AUDITORY 16 0.0010
572 UPPER LIMB FRACTURE 20 0.0010
573 PERIPHERAL SWELLING 154 0.0010
574 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
575 CARDIAC ARREST 82 0.0010
576 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
577 POST PROCEDURAL COMPLICATION 19 0.0010
578 OSTEOPENIA 15 0.0010
579 HAND FRACTURE 7 0.0010
580 THERMAL BURN 7 0.0010
581 DISORIENTATION 39 0.0010
582 ABDOMINAL PAIN UPPER 202 0.0010
583 SKIN INFECTION 11 0.0010
584 HEART RATE INCREASED 97 0.0010
585 ESCHERICHIA INFECTION 8 0.0010
586 KIDNEY INFECTION 19 0.0010
587 ANXIETY 275 0.0010
588 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
589 PANIC ATTACK 35 0.0010
590 DRUG USE DISORDER 8 0.0010
591 INFUSION SITE ERYTHEMA 8 0.0009
592 SCRATCH 10 0.0009
593 SCIATICA 15 0.0009
594 LUNG DISORDER 46 0.0009
595 HYPERCHOLESTEROLAEMIA 9 0.0009
596 PHARYNGEAL SWELLING 9 0.0009
597 NODULE 12 0.0009
598 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
599 DISSOCIATION 7 0.0009
600 GROIN PAIN 8 0.0009
601 RASH 397 0.0009
602 SPINAL OSTEOARTHRITIS 8 0.0009
603 BURSITIS 11 0.0009
604 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
605 INFECTION 131 0.0009
606 ANKLE FRACTURE 14 0.0009
607 UNDERDOSE 66 0.0009
608 FOOT DEFORMITY 10 0.0009
609 RESPIRATORY DEPRESSION 11 0.0009
610 HYPOKINESIA 13 0.0009
611 NEUROPATHY PERIPHERAL 85 0.0009
612 EMPHYSEMA 9 0.0009
613 BRONCHITIS 66 0.0009
614 HYPERCALCAEMIA 11 0.0009
615 PRODUCT ADMINISTRATION ERROR 18 0.0009
616 SEPSIS 99 0.0009
617 TASTE DISORDER 18 0.0009
618 SEROTONIN SYNDROME 17 0.0009
619 CONTUSION 85 0.0009
620 GLAUCOMA 17 0.0009
621 ABNORMAL LOSS OF WEIGHT 6 0.0009
622 NEUTROPHIL COUNT INCREASED 9 0.0009
623 MOBILITY DECREASED 63 0.0009
624 DEPRESSION 199 0.0009
625 MOVEMENT DISORDER 28 0.0009
626 MUSCULAR WEAKNESS 99 0.0009
627 RETINAL DETACHMENT 8 0.0009
628 MUSCLE DISORDER 7 0.0009
629 HOT FLUSH 65 0.0009
630 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
631 BACTERIAL INFECTION 16 0.0009
632 NAUSEA 678 0.0009
633 HEPATIC CIRRHOSIS 16 0.0009
634 ALOPECIA 167 0.0008
635 INCORRECT DOSE ADMINISTERED 193 0.0008
636 PANCREATITIS ACUTE 19 0.0008
637 LIP SWELLING 28 0.0008
638 POLLAKIURIA 35 0.0008
639 WITHDRAWAL SYNDROME 35 0.0008
640 THERAPY PARTIAL RESPONDER 13 0.0008
641 PANCREATITIS 44 0.0008
642 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 150 0.0008
643 PARAESTHESIA ORAL 12 0.0008
644 BLOOD POTASSIUM DECREASED 25 0.0008
645 ADVERSE REACTION 11 0.0008
646 DRUG INTOLERANCE 80 0.0008
647 BIPOLAR DISORDER 9 0.0008
648 MENTAL IMPAIRMENT 20 0.0008
649 FACIAL PARALYSIS 7 0.0008
650 RESPIRATORY TRACT CONGESTION 13 0.0008
651 ULCER 13 0.0008
652 BLOOD CHOLESTEROL INCREASED 38 0.0008
653 MUSCLE SPASTICITY 10 0.0008
654 VITREOUS FLOATERS 8 0.0008
655 ARTHRITIS 64 0.0008
656 DERMATITIS 17 0.0008
657 BLOOD MAGNESIUM DECREASED 7 0.0008
658 ARTHROPOD BITE 6 0.0008
659 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
660 RED BLOOD CELL COUNT DECREASED 23 0.0008
661 CHEST DISCOMFORT 82 0.0008
662 OCULAR HYPERAEMIA 38 0.0008
663 BLOOD CALCIUM INCREASED 7 0.0008
664 PRODUCT PRESCRIBING ERROR 19 0.0008
665 THROMBOCYTOPENIA 89 0.0008
666 JOINT SWELLING 96 0.0008
667 BRAIN OEDEMA 10 0.0008
668 VERTIGO 48 0.0008
669 PERICARDIAL EFFUSION 18 0.0008
670 HEAVY MENSTRUAL BLEEDING 7 0.0008
671 FEELING ABNORMAL 186 0.0008
672 WHEEZING 46 0.0008
673 LIMB INJURY 21 0.0008
674 SINUSITIS 79 0.0008
675 LIP DRY 7 0.0008
676 SPINAL PAIN 9 0.0008
677 EXOSTOSIS 7 0.0008
678 ABDOMINAL DISTENSION 80 0.0008
679 MUSCLE SPASMS 140 0.0008
680 HAND DEFORMITY 10 0.0008
681 JOINT STIFFNESS 20 0.0008
682 DIZZINESS 377 0.0008
683 ACCIDENT 9 0.0008
684 FUNGAL INFECTION 25 0.0007
685 DIARRHOEA HAEMORRHAGIC 7 0.0007
686 SENSORY DISTURBANCE 12 0.0007
687 NEOPLASM PROGRESSION 26 0.0007
688 PHOTOPHOBIA 14 0.0007
689 MEMORY IMPAIRMENT 102 0.0007
690 COLD SWEAT 13 0.0007
691 COMA 35 0.0007
692 PRODUCT DISPENSING ERROR 16 0.0007
693 THERAPY NON-RESPONDER 33 0.0007
694 SPINAL OPERATION 9 0.0007
695 RIB FRACTURE 15 0.0007
696 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 147 0.0007
697 ATELECTASIS 7 0.0007
698 SINUS BRADYCARDIA 7 0.0007
699 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
700 AUTOIMMUNE DISORDER 7 0.0007
701 HUNGER 10 0.0007
702 TOXICITY TO VARIOUS AGENTS 121 0.0007
703 HYPERSENSITIVITY 133 0.0007
704 ADVERSE DRUG REACTION 64 0.0007
705 RASH ERYTHEMATOUS 34 0.0007
706 TENDONITIS 11 0.0007
707 NERVOUSNESS 37 0.0007
708 DISABILITY 14 0.0007
709 LYMPHADENOPATHY 25 0.0007
710 ASTHENIA 264 0.0007
711 FEELING HOT 43 0.0007
712 CHOLECYSTECTOMY 8 0.0007
713 BLOOD PRESSURE INCREASED 107 0.0007
714 INFUSION SITE PAIN 9 0.0007
715 THINKING ABNORMAL 13 0.0007
716 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
717 SEPTIC SHOCK 30 0.0007
718 GASTROENTERITIS 10 0.0007
719 BEDRIDDEN 9 0.0007
720 LYMPHOCYTE COUNT DECREASED 12 0.0007
721 TEMPERATURE INTOLERANCE 7 0.0007
722 CHOLESTASIS 13 0.0007
723 LOSS OF CONSCIOUSNESS 86 0.0007
724 PETECHIAE 7 0.0007
725 DRUG-INDUCED LIVER INJURY 21 0.0007
726 EYE DISORDER 22 0.0007
727 GOUT 12 0.0007
728 SINUS CONGESTION 9 0.0007
729 MOUTH ULCERATION 14 0.0007
730 ARTHRALGIA 276 0.0007
731 SUDDEN DEATH 7 0.0007
732 PNEUMONITIS 18 0.0007
733 STOMATITIS 40 0.0007
734 THERAPY INTERRUPTED 47 0.0007
735 JOINT INJURY 14 0.0007
736 RESPIRATORY ARREST 18 0.0007
737 TACHYCARDIA 58 0.0007
738 SMALL INTESTINAL OBSTRUCTION 8 0.0006
739 DIVERTICULITIS 18 0.0006
740 ABDOMINAL PAIN 150 0.0006
741 NECK PAIN 36 0.0006
742 MUSCULOSKELETAL DISCOMFORT 11 0.0006
743 INTESTINAL OBSTRUCTION 24 0.0006
744 SINUS TACHYCARDIA 9 0.0006
745 DYSPEPSIA 62 0.0006
746 PARALYSIS 9 0.0006
747 OVERDOSE 135 0.0006
748 REBOUND EFFECT 7 0.0006
749 PLATELET COUNT DECREASED 66 0.0006
750 CONFUSIONAL STATE 100 0.0006
751 EXTRA DOSE ADMINISTERED 25 0.0006
752 FEMUR FRACTURE 19 0.0006
753 DEAFNESS 16 0.0006
754 SYNOVITIS 11 0.0006
755 SWOLLEN TONGUE 19 0.0006
756 RHEUMATOID ARTHRITIS 69 0.0006
757 SKIN HAEMORRHAGE 9 0.0006
758 SARS-COV-2 TEST POSITIVE 8 0.0006
759 IMMUNODEFICIENCY 9 0.0006
760 INFLAMMATION 31 0.0006
761 ADVERSE EVENT 55 0.0006
762 HEADACHE 373 0.0006
763 FEAR 16 0.0006
764 UNEVALUABLE EVENT 45 0.0006
765 EYE SWELLING 22 0.0006
766 URTICARIA 99 0.0006
767 EPISTAXIS 44 0.0006
768 PARAESTHESIA 92 0.0006
769 OROPHARYNGEAL PAIN 54 0.0006
770 NIGHTMARE 20 0.0006
771 BACK PAIN 134 0.0006
772 MALAISE 252 0.0006
773 RASH PRURITIC 31 0.0006
774 CARPAL TUNNEL SYNDROME 8 0.0006
775 HERNIA 11 0.0006
776 DEVICE OCCLUSION 8 0.0006
777 EAR PAIN 11 0.0006
778 THERAPY CESSATION 29 0.0006
779 CYST 7 0.0006
780 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
781 HYPOTHYROIDISM 18 0.0006
782 LACRIMATION INCREASED 17 0.0006
783 PRODUCT STORAGE ERROR 49 0.0006
784 IRRITABLE BOWEL SYNDROME 12 0.0006
785 CATARACT 33 0.0006
786 ABDOMINAL PAIN LOWER 14 0.0006
787 FAECES DISCOLOURED 12 0.0006
788 BLOOD PRESSURE ABNORMAL 11 0.0006
789 BACK INJURY 6 0.0006
790 PRESCRIBED UNDERDOSE 11 0.0006
791 PELVIC PAIN 10 0.0005
792 SPINAL FRACTURE 11 0.0005
793 PAIN 336 0.0005
794 PALPITATIONS 64 0.0005
795 FULL BLOOD COUNT DECREASED 11 0.0005
796 STAPHYLOCOCCAL INFECTION 18 0.0005
797 MIGRAINE 52 0.0005
798 GENERAL PHYSICAL HEALTH DETERIORATION 63 0.0005
799 THERAPEUTIC RESPONSE DECREASED 33 0.0005
800 RASH MACULAR 19 0.0005
801 DYSURIA 20 0.0005
802 ACNE 41 0.0005
803 HIATUS HERNIA 7 0.0005
804 INJURY 38 0.0005
805 TOOTH DISORDER 12 0.0005
806 CANDIDA INFECTION 9 0.0005
807 HYPOAESTHESIA ORAL 8 0.0005
808 PAIN IN JAW 15 0.0005
809 FRACTURE 10 0.0005
810 CHEST PAIN 97 0.0005
811 SWELLING 49 0.0005
812 TINNITUS 24 0.0005
813 JOINT RANGE OF MOTION DECREASED 7 0.0005
814 SKIN EXFOLIATION 44 0.0005
815 HALLUCINATION, VISUAL 11 0.0005
816 DRY EYE 26 0.0005
817 EYE PAIN 29 0.0005
818 SKIN FISSURES 10 0.0005
819 HEPATIC FUNCTION ABNORMAL 19 0.0005
820 ASTHMA 57 0.0005
821 METABOLIC ACIDOSIS 16 0.0005
822 BURNING SENSATION 35 0.0005
823 HYPERHIDROSIS 64 0.0005
824 GASTRIC DISORDER 17 0.0005
825 ACCIDENTAL OVERDOSE 18 0.0005
826 LIVER INJURY 12 0.0005
827 OSTEOPOROSIS 20 0.0005
828 NO ADVERSE EVENT 88 0.0005
829 PAIN IN EXTREMITY 142 0.0005
830 ROAD TRAFFIC ACCIDENT 20 0.0005
831 COLITIS ULCERATIVE 21 0.0005
832 INTENTIONAL PRODUCT MISUSE 41 0.0005
833 VISUAL IMPAIRMENT 58 0.0005
834 PSORIASIS 61 0.0005
835 RECTAL HAEMORRHAGE 20 0.0005
836 DYSPNOEA 263 0.0005
837 HYPERTENSION 98 0.0005
838 CHILLS 54 0.0005
839 HAEMOGLOBIN DECREASED 47 0.0005
840 HEAD DISCOMFORT 8 0.0005
841 EXPIRED PRODUCT ADMINISTERED 15 0.0005
842 LIVER DISORDER 20 0.0005
843 COLITIS 17 0.0004
844 SNEEZING 10 0.0004
845 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
846 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
847 AKATHISIA 6 0.0004
848 ABSCESS 7 0.0004
849 HERPES ZOSTER 25 0.0004
850 SHOCK 10 0.0004
851 ANAPHYLACTIC REACTION 24 0.0004
852 HYPOAESTHESIA 65 0.0004
853 TOOTH LOSS 9 0.0004
854 BRADYCARDIA 23 0.0004
855 BLOOD POTASSIUM INCREASED 7 0.0004
856 SWELLING FACE 28 0.0004
857 DEMENTIA 12 0.0004
858 WOUND 12 0.0004
859 ERYTHEMA 88 0.0004
860 DYSPHONIA 25 0.0004
861 BLOOD TEST ABNORMAL 6 0.0004
862 TARDIVE DYSKINESIA 12 0.0004
863 INFLUENZA LIKE ILLNESS 35 0.0004
864 VENTRICULAR TACHYCARDIA 7 0.0004
865 EXPOSURE DURING PREGNANCY 26 0.0004
866 MULTIPLE SCLEROSIS 20 0.0004
867 EYE PRURITUS 14 0.0004
868 NERVOUS SYSTEM DISORDER 13 0.0004
869 BLOOD GLUCOSE DECREASED 20 0.0004
870 ANOSMIA 6 0.0004
871 ANAEMIA 79 0.0004
872 LOCALISED INFECTION 10 0.0004
873 SKIN DISCOLOURATION 19 0.0004
874 DISCOMFORT 25 0.0004
875 COMPLETED SUICIDE 34 0.0004
876 VISION BLURRED 56 0.0004
877 RENAL DISORDER 19 0.0004
878 CARDIO-RESPIRATORY ARREST 17 0.0004
879 HAEMATOCRIT DECREASED 8 0.0004
880 ARRHYTHMIA 19 0.0004
881 SKIN LESION 11 0.0004
882 PRODUCT SUBSTITUTION ISSUE 23 0.0004
883 AMENORRHOEA 7 0.0004
884 ABNORMAL DREAMS 11 0.0004
885 CELLULITIS 20 0.0004
886 CHOLELITHIASIS 13 0.0004
887 HYPOTENSION 79 0.0004
888 BLISTER 22 0.0004
889 RESTLESS LEGS SYNDROME 7 0.0004
890 PULMONARY OEDEMA 17 0.0004
891 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
892 CONJUNCTIVITIS 7 0.0004
893 LABORATORY TEST ABNORMAL 11 0.0004
894 PULMONARY FIBROSIS 7 0.0004
895 AGEUSIA 9 0.0004
896 BLOOD UREA INCREASED 6 0.0004
897 PRURITUS 136 0.0004
898 HEPATITIS 9 0.0004
899 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
900 CEREBROVASCULAR ACCIDENT 59 0.0003
901 HYPOKALAEMIA 16 0.0003
902 LIVER FUNCTION TEST ABNORMAL 10 0.0003
903 NIGHT SWEATS 11 0.0003
904 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
905 BLOOD CREATININE INCREASED 22 0.0003
906 FLUSHING 34 0.0003
907 JAUNDICE 9 0.0003
908 BLOOD BILIRUBIN INCREASED 9 0.0003
909 CARDIAC DISORDER 31 0.0003
910 SUICIDE ATTEMPT 20 0.0003
911 MYALGIA 56 0.0003
912 TYPE 2 DIABETES MELLITUS 11 0.0003
913 HAEMORRHAGE 34 0.0003
914 PRODUCT QUALITY ISSUE 44 0.0003
915 NEUTROPHIL COUNT DECREASED 13 0.0003
916 HEPATOTOXICITY 7 0.0003
917 RASH GENERALISED 8 0.0003
918 DRY SKIN 41 0.0003
919 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
920 ACUTE MYOCARDIAL INFARCTION 9 0.0003
921 DISEASE PROGRESSION 36 0.0003
922 SYNCOPE 30 0.0003
923 HEPATIC FAILURE 9 0.0003
924 THROMBOSIS 24 0.0003
925 HYPERKALAEMIA 10 0.0003
926 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
927 LACTIC ACIDOSIS 9 0.0003
928 OEDEMA 15 0.0003
929 FLUID RETENTION 14 0.0003
930 BLOOD PRESSURE DECREASED 18 0.0003
931 PULMONARY EMBOLISM 25 0.0003
932 PLEURAL EFFUSION 16 0.0003
933 THROAT TIGHTNESS 7 0.0003
934 GYNAECOMASTIA 8 0.0003
935 BONE DENSITY DECREASED 8 0.0003
936 NEOPLASM MALIGNANT 17 0.0003
937 HAEMOPTYSIS 7 0.0003
938 INTENTIONAL OVERDOSE 16 0.0002
939 DRUG DEPENDENCE 40 0.0002
940 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
941 VISUAL ACUITY REDUCED 8 0.0002
942 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
943 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
944 HYPONATRAEMIA 13 0.0002
945 DELIRIUM 8 0.0002
946 DRUG WITHDRAWAL SYNDROME 20 0.0002
947 CEREBRAL HAEMORRHAGE 8 0.0002
948 DEVICE BREAKAGE 9 0.0002
949 BLINDNESS 9 0.0002
950 LEUKOPENIA 11 0.0002
951 SKIN IRRITATION 10 0.0002
952 ATRIAL FIBRILLATION 21 0.0002
953 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
954 IMPAIRED HEALING 7 0.0002
955 DISEASE RECURRENCE 10 0.0002
956 DIABETES MELLITUS 16 0.0002
957 EYE IRRITATION 12 0.0002
958 HYPOGLYCAEMIA 10 0.0002
959 RENAL IMPAIRMENT 17 0.0002
960 NEUTROPENIA 27 0.0002
961 FOETAL EXPOSURE DURING PREGNANCY 16 0.0002
962 PANCYTOPENIA 11 0.0002
963 HYPERGLYCAEMIA 7 0.0002
964 DYSPNOEA EXERTIONAL 7 0.0002
965 ACUTE KIDNEY INJURY 28 0.0002
966 MYOCARDIAL INFARCTION 31 0.0002
967 BLOOD GLUCOSE INCREASED 33 0.0002
968 DYSGEUSIA 13 0.0002
969 CARDIAC FAILURE 14 0.0002
970 PROSTATE CANCER 14 0.0002
971 EMOTIONAL DISTRESS 21 0.0002
972 MUSCULOSKELETAL PAIN 9 0.0002
973 INJECTION SITE SWELLING 13 0.0002
974 RENAL FAILURE 22 0.0002
975 HYPOACUSIS 7 0.0002
976 MEDICATION ERROR 9 0.0002
977 DEVICE DISLOCATION 7 0.0002
978 DEVICE ISSUE 14 0.0002
979 BONE PAIN 9 0.0002
980 SKIN BURNING SENSATION 11 0.0002
981 DERMATITIS ATOPIC 8 0.0002
982 INJECTION SITE BRUISING 12 0.0002
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
984 OEDEMA PERIPHERAL 17 0.0001
985 DEEP VEIN THROMBOSIS 9 0.0001
986 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
987 ANGIOEDEMA 6 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
989 INJECTION SITE PAIN 27 0.0001
990 INJECTION SITE HAEMORRHAGE 7 0.0001
991 BREAST CANCER 7 0.0001
992 INJECTION SITE ERYTHEMA 8 0.0001